Wedbush Securities’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-15,498
Closed -$37K 1233
2024
Q1
$37K Hold
15,498
﹤0.01% 1216
2023
Q4
$26K Hold
15,498
﹤0.01% 1074
2023
Q3
$30K Hold
15,498
﹤0.01% 1040
2023
Q2
$22K Hold
15,498
﹤0.01% 1052
2023
Q1
$33K Sell
15,498
-9,000
-37% -$19.2K ﹤0.01% 1052
2022
Q4
$28K Sell
24,498
-500
-2% -$571 ﹤0.01% 1029
2022
Q3
$41K Sell
24,998
-3,000
-11% -$4.92K ﹤0.01% 1012
2022
Q2
$37K Hold
27,998
﹤0.01% 1044
2022
Q1
$45K Sell
27,998
-2,000
-7% -$3.22K ﹤0.01% 1078
2021
Q4
$62K Sell
29,998
-1,000
-3% -$2.07K ﹤0.01% 1150
2021
Q3
$120K Buy
30,998
+13,000
+72% +$50.3K 0.01% 1117
2021
Q2
$58K Hold
17,998
﹤0.01% 1144
2021
Q1
$39K Sell
17,998
-2,500
-12% -$5.42K ﹤0.01% 1066
2020
Q4
$46K Buy
20,498
+3,000
+17% +$6.73K ﹤0.01% 857
2020
Q3
$47K Sell
17,498
-3,000
-15% -$8.06K ﹤0.01% 887
2020
Q2
$63K Hold
20,498
0.01% 892
2020
Q1
$40K Sell
20,498
-1,000
-5% -$1.95K ﹤0.01% 835
2019
Q4
$61K Hold
21,498
0.01% 956
2019
Q3
$79K Sell
21,498
-3,000
-12% -$11K 0.01% 914
2019
Q2
$102K Buy
24,498
+6,500
+36% +$27.1K 0.01% 902
2019
Q1
$92K Hold
17,998
0.01% 861
2018
Q4
$62K Hold
17,998
0.01% 784
2018
Q3
$108K Hold
17,998
0.01% 837
2018
Q2
$114K Sell
17,998
-18,000
-50% -$114K 0.01% 800
2018
Q1
$171K Buy
35,998
+5,499
+18% +$26.1K 0.02% 706
2017
Q4
$102K Buy
+30,499
New +$102K 0.01% 786